The continuing value of mesalazine as first-line therapy for patients with moderately active ulcerative colitis
{{output}}
Mesalazine is an established and recommended first-line treatment for mild-to-moderate ulcerative colitis (UC). For patients with moderately active UC, the choice to use mesalazine or to initiate treatment with an oral corticosteroid or anti-tumor necrosis fac... ...
